GRAIL, Inc. (GRAL)
54.42
+3.77
(+7.44%)
USD |
NASDAQ |
Apr 24, 16:00
54.35
-0.07
(-0.13%)
Pre-Market: 20:00
GRAIL EPS Diluted (Quarterly) : -2.435 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodesix, Inc. | -0.4935 |
| FONAR Corp. | 0.3058 |
| Interpace Biosciences, Inc. | 0.8178 |
| Thermo Fisher Scientific, Inc. | 4.43 |
| XWELL, Inc. | -3.036 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -99.18M |
| Revenue (Quarterly) | 43.60M |
| Total Expenses (Quarterly) | 142.77M |
| Enterprise Value | 1.383B |
| Gross Profit Margin (Quarterly) | -33.70% |
| Profit Margin (Quarterly) | -227.5% |
| Earnings Yield | -20.54% |
| Normalized Earnings Yield | -19.54 |